BI

Biotest AGXETRA Biotest Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

1.519

Small

Exchange

XETR - Xetra

BIO.DE Stock Analysis

BI

Uncovered

Biotest AG is uncovered by Eyestock quantitative analysis.

Market cap $B

1.519

Dividend yield

0.18 %

Shares outstanding

39.571 B

Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

View Section: Eyestock Rating